Xinping Cao

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Selective Confinement by a COF-Derived Sub-Nanoporous Interface for High-Performance CoF2 Thermal Battery Cathodes.

Selective Confinement by a COF-Derived Sub-Nanoporous Interface for High-Performance CoF2 Thermal Battery Cathodes.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 24, 2025

A novel fourth generation of CAR-T cells: CD19 CAR-T cells engineered to express membrane-bound interleukin-15 and CXCR5 for the treatment of lymphoma.

A novel fourth generation of CAR-T cells: CD19 CAR-T cells engineered to express membrane-bound interleukin-15 and CXCR5 for the treatment of lymphoma.

Journal: Clinical and experimental medicine

Published: June 12, 2025

A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis.

A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis.

Journal: Frontiers in oncology

Published: December 22, 2024

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.

Journal: Frontiers in immunology

Published: September 04, 2024

Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemia.

Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemia.

Journal: Chinese medical journal

Published: May 07, 2024

Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemia.

Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemia.

Journal: Chinese medical journal

Published: May 05, 2024

Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation.

Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation.

Journal: Leukemia

Published: December 07, 2023

A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram.

A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram.

Journal: Cancer immunology, immunotherapy : CII

Published: August 20, 2023

The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.

The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.

Journal: BMC medical genomics

Published: July 06, 2023

Alliance between titans: combination strategies of CAR-T cell therapy and oncolytic virus for the treatment of hematological malignancies.

Alliance between titans: combination strategies of CAR-T cell therapy and oncolytic virus for the treatment of hematological malignancies.

Journal: Annals of hematology

Published: June 17, 2023

Role of chemokines in T-cell acute lymphoblastic Leukemia: From pathogenesis to therapeutic options.

Role of chemokines in T-cell acute lymphoblastic Leukemia: From pathogenesis to therapeutic options.

Journal: International immunopharmacology

Published: March 14, 2023

Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escape.

Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escape.

Journal: Translational oncology

Published: February 14, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026